Abstract Details

Title Trends in Outcome and Hospitalization Charges of Pediatric Patients Admitted with Guillain Barre Syndrome in the United States. Data from Kids' Inpatient Database (KID) 1997-2009

Topic Peripheral Nerve

Presentation(s) P01 - (-)

Poster/Presentation
Number 136

Objective

Background BACKGROUND: The advance in understanding of GBS has led to the development of more effective therapeutic strategies including pulmonary support and mechanical ventilation.

Design/Methods DESIGN/METHODS: We determined the rates of occurrence, in-hospital outcomes, and mean hospital charges for pediatric patients hospitalized with GBS from 1997 to 2009 using the Kids inpatient Database (KID).

Results RESULTS: There was a steady increase in the number of GBS patients from 1997 to 2009: 333 and 585 patients in 1997 and 2009 respectively. The average patient's age was significantly different in the studied time periods (minimum average age was 9.5±5.6 years in 1997 and maximum average age was 11.1±6.1 years in 2009, p<0.001). There was a non-significant reduction in the length of stay from 1997 (10.2±14.0 days) to 2009 (8.3±9.1 days). During the study time period, there were two deaths reported, both in 2003. There was a significant and steady increase in average hospital charges over time: $30,010±46,391 in 1997 and 73,538± 98,536 in 2009, p<0.001. This difference persisted after adjustment for inflation.

Conclusions CONCLUSIONS: There was a steady increase in the number of pediatric GBS patients from 1997 to 2009. There was a significant and steady increase in in-hospital charges of patients admitted for GBS from 1997 to 2009 that was paralleled by a significant increase in average age and a non significant reduction in the length of hospitalization.

Authors/Disclosures
Howard W. Sander, MD, FAAN PRESENTER	Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Rania A. Elenein, MD (Jefferson Health NJ)	Dr. Elenein has nothing to disclose.
Wenzhuan He, MD (UPMC Susquehanna Neurology)	Dr. He has nothing to disclose.
	No disclosure on file
Zaid Al-Qudah, MD (Associate Specialist Inc.)	No disclosure on file
Nizar Souayah, MD, FAAN (NJMS)	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
	No disclosure on file

��ɫ��

��ɫ��